mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.009 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.009 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.009 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.01 |